A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a fatal disease of the lower respiratory tract with restricted therapeutic options. Repetitive injury of the bronchoalveolar epithelium leads to activation of pulmonary fibroblasts, differentiation into myofibroblasts and excessive extracellular matrix (ECM) de...

Full description

Bibliographic Details
Main Authors: Julia Nemeth, Annika Schundner, Karsten Quast, Veronika E. Winkelmann, Manfred Frick
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.567675/full
_version_ 1818890409200320512
author Julia Nemeth
Annika Schundner
Karsten Quast
Veronika E. Winkelmann
Manfred Frick
author_facet Julia Nemeth
Annika Schundner
Karsten Quast
Veronika E. Winkelmann
Manfred Frick
author_sort Julia Nemeth
collection DOAJ
description Idiopathic pulmonary fibrosis (IPF) is a fatal disease of the lower respiratory tract with restricted therapeutic options. Repetitive injury of the bronchoalveolar epithelium leads to activation of pulmonary fibroblasts, differentiation into myofibroblasts and excessive extracellular matrix (ECM) deposition resulting in aberrant wound repair. However, detailed molecular and cellular mechanisms underlying initiation and progression of fibrotic changes are still elusive. Here, we report the generation of a representative fibroblast reporter cell line (10-4ABFP) to study pathophysiological mechanisms of IPF in high throughput or high resolution in vitro live cell assays. To this end, we immortalized primary fibroblasts isolated from the distal lung of Sprague-Dawley rats. Molecular and transcriptomic characterization identified clone 10-4A as a matrix fibroblast subpopulation. Mechanical or chemical stimulation induced a reversible fibrotic state comparable to effects observed in primary isolated fibroblasts. Finally, we generated a reporter cell line (10-4ABFP) to express nuclear blue fluorescent protein (BFP) under the promotor of the myofibroblast marker alpha smooth muscle actin (Acta2) using CRISPR/Cas9 technology. We evaluated the suitability of 10-4ABFP as reporter tool in plate reader assays. In summary, the 10-4ABFP cell line provides a novel tool to study fibrotic processes in vitro to gain new insights into the cellular and molecular processes involved in fibrosis formation and propagation.
first_indexed 2024-12-19T17:24:27Z
format Article
id doaj.art-6c75d968925a4f5998087629576e6e89
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-19T17:24:27Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-6c75d968925a4f5998087629576e6e892022-12-21T20:12:36ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2020-10-011110.3389/fphys.2020.567675567675A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary FibrosisJulia Nemeth0Annika Schundner1Karsten Quast2Veronika E. Winkelmann3Manfred Frick4Institute of General Physiology, Ulm University, Ulm, GermanyInstitute of General Physiology, Ulm University, Ulm, GermanyBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyInstitute of General Physiology, Ulm University, Ulm, GermanyInstitute of General Physiology, Ulm University, Ulm, GermanyIdiopathic pulmonary fibrosis (IPF) is a fatal disease of the lower respiratory tract with restricted therapeutic options. Repetitive injury of the bronchoalveolar epithelium leads to activation of pulmonary fibroblasts, differentiation into myofibroblasts and excessive extracellular matrix (ECM) deposition resulting in aberrant wound repair. However, detailed molecular and cellular mechanisms underlying initiation and progression of fibrotic changes are still elusive. Here, we report the generation of a representative fibroblast reporter cell line (10-4ABFP) to study pathophysiological mechanisms of IPF in high throughput or high resolution in vitro live cell assays. To this end, we immortalized primary fibroblasts isolated from the distal lung of Sprague-Dawley rats. Molecular and transcriptomic characterization identified clone 10-4A as a matrix fibroblast subpopulation. Mechanical or chemical stimulation induced a reversible fibrotic state comparable to effects observed in primary isolated fibroblasts. Finally, we generated a reporter cell line (10-4ABFP) to express nuclear blue fluorescent protein (BFP) under the promotor of the myofibroblast marker alpha smooth muscle actin (Acta2) using CRISPR/Cas9 technology. We evaluated the suitability of 10-4ABFP as reporter tool in plate reader assays. In summary, the 10-4ABFP cell line provides a novel tool to study fibrotic processes in vitro to gain new insights into the cellular and molecular processes involved in fibrosis formation and propagation.https://www.frontiersin.org/article/10.3389/fphys.2020.567675/fullidiopathic pulmonary fibrosislungmyofibroblastTGF-βextracellular matrixalpha smooth muscle actin
spellingShingle Julia Nemeth
Annika Schundner
Karsten Quast
Veronika E. Winkelmann
Manfred Frick
A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
Frontiers in Physiology
idiopathic pulmonary fibrosis
lung
myofibroblast
TGF-β
extracellular matrix
alpha smooth muscle actin
title A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
title_full A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
title_fullStr A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
title_full_unstemmed A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
title_short A Novel Fibroblast Reporter Cell Line for in vitro Studies of Pulmonary Fibrosis
title_sort novel fibroblast reporter cell line for in vitro studies of pulmonary fibrosis
topic idiopathic pulmonary fibrosis
lung
myofibroblast
TGF-β
extracellular matrix
alpha smooth muscle actin
url https://www.frontiersin.org/article/10.3389/fphys.2020.567675/full
work_keys_str_mv AT julianemeth anovelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT annikaschundner anovelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT karstenquast anovelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT veronikaewinkelmann anovelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT manfredfrick anovelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT julianemeth novelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT annikaschundner novelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT karstenquast novelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT veronikaewinkelmann novelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis
AT manfredfrick novelfibroblastreportercelllineforinvitrostudiesofpulmonaryfibrosis